🇺🇸 FDA
Pipeline program

Buprenorphine/Naloxone

HPTN 058

Phase 3 small_molecule terminated

Quick answer

Buprenorphine/Naloxone for HIV Infections is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
HIV Infections
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials